Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q2 EPS of ($0.35), $0.05 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.